Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← David Einhorn, latest 13F

Coya Therapeutics

In David Einhorn's portfolio · Greenlight Capital

Ticker COYA

Still in the portfolio as of Q3 2026. Every quarter it shows up in a Greenlight Capital 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q3 2026 No change 2,335,540 0.3% $5.01 $11.7M
Q2 2026 No change 2,335,540 0.3% $5.85 $13.7M
Q1 2026 Add 15% 2,335,540 0.3% $3.94 $9.2M
Q4 2025 Add 23% 2,025,940 0.4% $5.80 $11.8M
Q3 2025 No change 1,646,440 0.4% $5.70 $9.4M
Q2 2025 No change 1,646,440 0.4% $5.75 $9.5M
Q1 2025 No change 1,646,440 0.5% $6.47 $10.7M
Q4 2024 Add 29% 1,646,440 0.5% $5.73 $9.4M
Q3 2024 No change 1,274,026 0.3% $6.45 $8.2M
Q2 2024 No change 1,274,026 0.4% $6.06 $7.7M
Q1 2024 No change 1,274,026 0.6% $9.92 $12.6M
Q4 2023 Add 172% 1,274,026 0.5% $7.41 $9.4M
Q3 2023 Add 19% 468,067 0.1% $3.84 $1.8M
Q2 2023 No change 392,647 0.1% $4.07 $1.6M
Q1 2023 No change 392,647 0.1% $3.97 $1.6M
Q4 2022 Buy 392,444 0.1% $4.74 $1.9M

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.